NCT03101514 2021-06-23
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Phase 2 Completed
Clinical Trials
4 trialsNCT02553187 2017-02-15
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Phase 4 Unknown
NCT01640730 2014-01-16
Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer
KangLaiTe USA
Phase 2 Terminated
NCT00031031 2007-11-27
Kanglaite Injection Phase I Study
KangLaiTe USA
Phase 1 Completed